These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 328291)
21. [Testing and control of therapeutic materials and drugs]. Dollery CT Acta Odontol Venez; 1973 Apr; 11(1):28-38. PubMed ID: 4143801 [No Abstract] [Full Text] [Related]
22. Statisical logic in the monitoring of reactions to therapeutic drugs. Finney DJ Methods Inf Med; 1971 Oct; 10(4):237-45. PubMed ID: 5124593 [No Abstract] [Full Text] [Related]
23. [France in the European cooperation for the technological evaluation of health products]. Meyer F Med Sci (Paris); 2018 May; 34 Hors série n°1():57-59. PubMed ID: 29911568 [No Abstract] [Full Text] [Related]
24. Proceedings: Anticancer drug development programs: a comparison of approaches in the United States, the Soviet Union, Japan, and Western Europe. Carter SK Natl Cancer Inst Monogr; 1974 Feb; 40():31-45. PubMed ID: 4819407 [No Abstract] [Full Text] [Related]
25. New submissions adding to federal government's drug-approval backlog. Rafuse J CMAJ; 1991 Feb; 144(4):486-7. PubMed ID: 1993299 [No Abstract] [Full Text] [Related]
27. Towards research equity -- challenges of safety monitoring during clinical trials in resource-limited settings. Van den Broeck J; Robinson AK West Indian Med J; 2007 Mar; 56(2):163-5. PubMed ID: 17910148 [No Abstract] [Full Text] [Related]
28. [Basic principles of clinical evaluation of medications]. Cichutek K Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):395-6. PubMed ID: 15830248 [No Abstract] [Full Text] [Related]
29. Patients' needs in drug development and regulation. Wardell WM Ann N Y Acad Sci; 1981; 368():187-202. PubMed ID: 7020538 [No Abstract] [Full Text] [Related]
30. Timolol: a preliminary report of its pharmacological properties and therapeutic efficacy in angina and hypertension. Brogden RN; Speight TM; Avery GS Drugs; 1975; 9(3):164-77. PubMed ID: 236167 [TBL] [Abstract][Full Text] [Related]
31. Post-marketing surveillance of adverse reactions to new medicines. Wilson AB Br Med J; 1977 Oct; 2(6093):1001-3. PubMed ID: 922357 [No Abstract] [Full Text] [Related]
32. Drug trials in developing countries: the need for ethics. Mbuyi-Muamba JM World Health Forum; 1993; 14(1):28-9. PubMed ID: 8439366 [TBL] [Abstract][Full Text] [Related]
33. Basic strategy for avoiding drug interaction during stage of drug development; proposals relative to planning of non-clinical and clinical studies and how clinical trials should be planned. Horie T; Nakata H; Kusube K J Toxicol Sci; 1996 Dec; 21(5):331-9. PubMed ID: 9035046 [No Abstract] [Full Text] [Related]
34. Industry concern over EU hepatotoxicity guidance. Hughes B Nat Rev Drug Discov; 2008 Sep; 7(9):719. PubMed ID: 19172685 [No Abstract] [Full Text] [Related]
35. [Drug therapy of EPH-gestosis]. Wode J Med Welt; 1976 Oct; 27(40):1900-3. PubMed ID: 824524 [No Abstract] [Full Text] [Related]
36. International challenge of drug abuse: a perspective from the United Nations. Ling GM; Gomez del Prado J NIDA Res Monogr; 1978; (19):60-8. PubMed ID: 106300 [No Abstract] [Full Text] [Related]
37. What to do until the FDA arrives. Riegelman RK Postgrad Med; 1981 Dec; 70(6):103-8. PubMed ID: 7031627 [TBL] [Abstract][Full Text] [Related]
38. Assuring the safety and efficacy of therapies. Stolley PD Int J Health Serv; 1974; 4(1):131-45. PubMed ID: 4597990 [TBL] [Abstract][Full Text] [Related]
39. [Clinical trial of analgesic and anti-inflammatory drugs]. Therapie; 1973; 28(5):833-60. PubMed ID: 4603408 [No Abstract] [Full Text] [Related]
40. [New order in drug legislation]. Feiden K Dtsch Med Wochenschr; 1975 Apr; 100(17):972-6. PubMed ID: 1091438 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]